â– LECTURE OVERVIEW: Neonatal Jaundice (hyperbilirubinemia) is a common clinical finding, classified chronologically into physiological and pathological profiles.
â– THE DYNAMIC SPLITS:
1. Physiological Jaundice (Normal/Benign):
- Pathogenesis: Caused by a transient, relative deficiency of hepatic UDP-glucuronosyltransferase (UGT) activity in a neonate with high red cell turnover.
- Timeline: Arises after the first 24 hours of life, peaking on days 3-5 before resolving.
2. Pathological Jaundice (Diseased):
- Pathogenesis: Driven by hemolysis (e.g., Rh/ABO incompatibility), biliary atresia, or sepsis.
- Timeline: Begins within the first 24 hours of life. Bilirubin levels rise quickly (>5 mg/dL/day or >15 mg/dL total).
â– EMERGENCY MANAGEMENT:
Acute presentation requires rapid stabilization following standard clinical guidelines. Prioritize securing the airway, maintaining hemodynamic stability, and administering targeted antidotes.
â– EMERGENCY DECREES & FAST-TRACK RESPONSES:
Upon presentation with extreme physiological disruption, initiate immediate volume restoration and broad-spectrum metabolic stabilization.
[HY-BOARD-1248]
🌟 Dynamic Clinical Key:
In pathological jaundice, high levels of unconjugated (indirect) bilirubin can cross the blood-brain barrier. Bilirubin deposits selectively in the basal ganglia, predisposing the neonate to acute bilirubin encephalopathy or permanent, devastating Kernicterus. Do not delay emergency interventions for low-priority diagnostic tests. Confirm central vital markers continually rather than relying solely on peripheral readings.